cg0070,pembrolizumab
merck,cg oncology,kissei
['mibc', 'cg0070', 'core1']
 's #asco22 abstract core1: phase 2 of cg0070 with pem in with umibc responsive to bcg. #asco22 #oncotwitter 
Produce, Find, and Distribute the latest and highest quality  multimedia to oncologists, hematologists and researchers.